The Foster Urological Oncology Support Fund advances groundbreaking research, education, and clinical care in urologic cancers at IU School of Medicine. Home to one of the world's leading programs in urologic oncology, the Department of Urology is recognized nationally for its expertise in treating prostate, bladder, kidney, and testicular cancers.

Led by Clint Cary, MD, MPH, MBA, the department has pioneered numerous innovations, including international collaborations, destination surgical programs, and contributions to clinical guidelines through large data cohorts in testicular and prostate cancer. Our team's efforts in clinical trials, advanced imaging (PSMA-PET), and translational research continue to shape the future of urologic cancer care.

Gifts to this fund fuel vital research initiatives, including but not limited to:

• Advancements in ctDNA applications for personalized treatment strategies
• Studies exploring cancer biology and platinum resistance in testicular cancer
• NIH, Department of Defense, and Prostate Cancer Foundation-funded investigations
• Research leading to improved surgical outcomes and quality of life for urologic oncology patients

Philanthropy bridges critical funding gaps, accelerating discoveries and ensuring patients receive the most advanced, compassionate care. With your support, IU School of Medicine will continue to drive innovation in urologic oncology and train the next generation of leaders in the field.

Please note, the name and purpose of the fund displayed on this page constitute the authorized description of the fund by the Indiana University Foundation, Inc. Your gift supports the fund as described herein.

Gifts will be administered by the Indiana University Foundation, Inc. which represents Indiana University, including the IU School of Medicine. This is not a gift to Indiana University Health, and the Indiana University Health Foundation will not play a role in administering these accounts.